{"id":398545,"date":"2020-12-11T20:55:07","date_gmt":"2020-12-12T01:55:07","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398545"},"modified":"2020-12-11T20:55:07","modified_gmt":"2020-12-12T01:55:07","slug":"weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/","title":{"rendered":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Dec. 11, 2020<\/span> \/PRNewswire\/ —<\/p>\n

\n

\n
\n \"WeissLaw
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n
\n If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:<\/u>
\n <\/b>\n <\/p>\n

\n
\n Joshua Rubin, Esq.<\/span>
\n
\n <\/b>WeissLaw LLP
1500 Broadway, 16th<\/sup> Floor
New York<\/span>, NY\u00a0 10036
(212)\u00a0682-3025
<\/b>(888) 593-4771
stockinfo@weisslawllp.com<\/a><\/u><\/b><\/p>\n

\n Eidos Therapeutics, Inc. (NASDAQ: EIDX)<\/b>\n <\/p>\n

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX)<\/b>\u00a0in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. (“BridgeBio”).\u00a0 Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26<\/span> for each share of EIDX common stock that they own, subject to proration such that the aggregate cash portion will not exceed $175 million<\/span>.\u00a0 Notably, there is an active alternative bidder offering nearly $50.00<\/span>\/share more that is currently being frozen out and prevented from engaging with EIDX.\u00a0 If you own EIDX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https:\/\/weisslawllp.com\/eidx\/<\/b><\/a><\/p>\n

\n Inphi Corporation (NASDAQ: IPHI)<\/b>\n <\/p>\n

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of\u00a0Inphi Corporation (NASDAQ: IPHI)<\/b>\u00a0in connection with the company’s proposed mixed cash-and-stock merger with Marvell Technology Group Ltd.\u00a0 Under the terms of the merger agreement, IPHI shareholders will receive $66.00<\/span> in cash and\u00a02.323 shares of the newly-combined company for each IPHI share that they own.\u00a0 If you own IPHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https:\/\/weisslawllp.com\/iphi\/<\/b><\/a><\/p>\n

\n Tengasco Inc. (NYSE: TGC)<\/b>\n <\/p>\n

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tengasco Inc. (NYSE: TGC)<\/b> in connection with the company’s proposed merger with privately-held Riley Exploration-Permian, LLC (“Riley”), pursuant to which TGC will issue shares of TGC common stock to Riley members and the new combined entity will trade under the new ticker symbol “REPX.” \u00a0If you own TGC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https:\/\/www.weisslawllp.com\/tgc\/<\/a><\/b>\u00a0 <\/u><\/b><\/p>\n

\n Apex Technology Acquisition Corporation<\/b>
\n \u00a0(NASDAQ: APXT)<\/b>\u00a0 <\/p>\n

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apex Technology Acquisition Corporation<\/b>(NASDAQ: APXT)<\/b>\u00a0in connection with the company’s proposed merger with AvePoint Inc. (“AvePoint”). \u00a0Under the terms of the agreement, APXT will acquire AvePoint through a reverse merger that will result in AvePoint becoming a public company.\u00a0\u00a0If you own APXT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https:\/\/www.weisslawllp.com\/apxt\/<\/a><\/b><\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations-301191512.html<\/a><\/p>\n

SOURCE WeissLaw LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK, Dec. 11, 2020 \/PRNewswire\/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP1500 Broadway, 16th FloorNew York, NY\u00a0 10036(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Eidos Therapeutics, Inc. (NASDAQ: EIDX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX)\u00a0in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. (“BridgeBio”).\u00a0 Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of … <\/p>\n

Continue reading “WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398545","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nWeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Dec. 11, 2020 \/PRNewswire\/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP1500 Broadway, 16th FloorNew York, NY\u00a0 10036(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Eidos Therapeutics, Inc. (NASDAQ: EIDX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX)\u00a0in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. (“BridgeBio”).\u00a0 Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of … Continue reading "WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-12T01:55:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations\",\"datePublished\":\"2020-12-12T01:55:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/\"},\"wordCount\":524,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/743985\\\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/\",\"name\":\"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/743985\\\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg\",\"datePublished\":\"2020-12-12T01:55:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/743985\\\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/743985\\\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/","og_locale":"en_US","og_type":"article","og_title":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk","og_description":"PR Newswire NEW YORK, Dec. 11, 2020 \/PRNewswire\/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP1500 Broadway, 16th FloorNew York, NY\u00a0 10036(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Eidos Therapeutics, Inc. (NASDAQ: EIDX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX)\u00a0in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. (“BridgeBio”).\u00a0 Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of … Continue reading \"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-12T01:55:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations","datePublished":"2020-12-12T01:55:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/"},"wordCount":524,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/","name":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg","datePublished":"2020-12-12T01:55:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/743985\/WeissLaw_Logo_Stacked_LowerCase_color_2_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/weisslaw-llp-reminds-eidx-iphi-tgc-and-apxt-shareholders-about-its-ongoing-investigations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398545"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398545\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}